敏捷响应临床试验可访问性在第一个COVID-19流行浪潮期间的关键需求
Stephanie Smith1, Frederick Millham2
1South Shore Hospital, Weymouth; Boston University School of Medicine, Boston, Massachusetts.
American journal of disaster medicine
|April 10, 2024
概括
临床研究人员在2019年冠状病毒疾病 (COVID-19) 疫情初期面临重大挑战. 这篇文章介绍了一个模型,以帮助机构规划未来的流行病和灾害.
科学领域:
- 临床研究 临床研究
- 流行病的准备 流行病的准备
- 公共卫生紧急情况 公共卫生紧急情况
背景情况:
- 2019年冠状病毒疾病 (COVID-19) 的出现给全球临床研究业务带来了前所未有的挑战.
- 流行病早期阶段突出了研究基础设施和响应协议的关键漏洞.
研究的目的:
- 确定和讨论临床研究社区在最初的COVID-19爆发期间遇到的主要障碍.
- 提出一个战略模型,以加强机构对未来的流行病和大规模灾害的准备.
主要方法:
- 对临床研究团队面临的挑战进行定性分析.
- 在研究环境中开发流行病应对的概念框架.
主要成果:
- 主要挑战包括供应链中断,监管障碍,参与者安全问题和劳动力适应.
- 拟议的模型为资源分配,风险管理和机构间合作提供了可行的策略.
结论:
- 随着COVID-19的爆发,人们越来越需要适应性和弹性临床研究系统.
- 实施结构化的准备模式对于减轻未来健康危机对研究连续性的影响至关重要.
相关概念视频
01:12Hazard Ratio
116
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
116
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126